Step by step guide to taking GLP-1 drops correctly Follow these instructions precisely
Chronic Disease Management: Increased use of GLP-1 medications may reduce the incidence of diabetes-related hospitalizations by 10%15% and cardiovascular events by up to 20%, improving long-term population health outcomes
Protocol 2: significant weight loss (20-25% body weight) Goal: Substantial weight reduction for health improvement Tirzepatide approach: Full escalation to 10-15 mg Expect to reach target dose by week 17-21 Weight loss at 15 mg: approximately 22.5% at 72 weeks Plateau typically occurs around weeks 60-72 Retatrutide approach: Full escalation to 8-12 mg Expect to reach target dose by week 13-17 Weight loss at 12 mg: 24.2% at 48 weeks, 28.7% at 68 weeks No plateau observed in trial data at 48 or 68 weeks For significant weight loss goals, retatrutide reaches 20%+ body weight reduction faster and ultimately achieves a higher ceiling
(USA) are currently the only two companies with GLP-1 medications approved for chronic weight management in the U.S
Venneti KC, Malthouse JP, OHarte FP, Hewage CM
Every order is dispatched by Canada Post with fast domestic shipping, so orders arrive without customs delays
